Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H39NO2 |
Molecular Weight | 409.6041 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC=C3C[C@@H](O)CC[C@]3(C)[C@@]1([H])CC4=C2C=CC([C@H](C)[C@]5([H])NC[C@@H](C)C[C@H]5O)=C4C
InChI
InChIKey=MALFODICFSIXPO-KFKQDBFTSA-N
InChI=1S/C27H39NO2/c1-15-11-25(30)26(28-14-15)17(3)20-7-8-21-22-6-5-18-12-19(29)9-10-27(18,4)24(22)13-23(21)16(20)2/h5,7-8,15,17,19,22,24-26,28-30H,6,9-14H2,1-4H3/t15-,17-,19-,22-,24-,25+,26-,27-/m0/s1
Molecular Formula | C27H39NO2 |
Molecular Weight | 409.6041 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Veratramine, a steroidal alkaloid originating from Veratrum nigrum L. CYP2D6 and SULT2A1 mediating hydroxylation and sulfation were identified as the major biotransformation for veratramine. Veratramine significantly inhibits the hedgehog pathway in NIH/3T3 cells. Veratramine is both a release and uptake inhibitor of serotonin. Veratramine exhibits cytotoxic activity against human tumor cell lines A549, PANC-1, SW1990 and NCI-H249. Veratramine has demonstrated distinct anti-hypertension effects in spontaneously hypertensive rats.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0001820 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1710298 |
|||
Target ID: GO:0051610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1710298 |
0.25 µM [Ki] | ||
Target ID: CHEMBL289 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25765359 |
33.0 µM [Ki] | ||
Target ID: CHEMBL2077 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25765359 |
|||
Target ID: map04340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20013819 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Puqienine F, a novel veratramine alkaloid from the bulbs of Fritillaria puqiensis. | 2006 May |
|
Development of in vitro techniques for the important medicinal plant Veratrum californicum. | 2006 Oct |
|
[Determination of vetatramine in Veratrum nigrum by HPLC-ELSD]. | 2008 Apr |
|
Hypotensive effect and toxicology of total alkaloids and veratramine from roots and rhizomes of Veratrum nigrum L. in spontaneously hypertensive rats. | 2008 Aug |
|
Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum. | 2008 Aug |
|
[Determination of jervine and veratramine in Veratrum plants using high performance liquid chromatography coupled with evaporative light scattering detection]. | 2008 Jan |
|
Isolation, purification, and full NMR assignments of cyclopamine from Veratrum californicum. | 2008 Jun 24 |
|
[Steroidal alkaloids of from Veratrum dahuricum]. | 2009 Dec |
|
Synthesis of all diastereomers of the piperidine--alkaloid substructure of cyclopamine. | 2009 Dec 3 |
|
Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum. | 2010 Jun |
|
Characterization and identification of steroidal alkaloids in Fritillaria species using liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. | 2010 Nov 5 |
|
Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified. | 2010 Sep 5 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18771011
0.56 to 2.24 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1710298
The uptake of 3H-5-HT into the frontal cortical slices was inhibited by veratramine in a concentration-dependent fashion with an IC50 of 0.13 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:47:49 GMT 2023
by
admin
on
Sat Dec 16 10:47:49 GMT 2023
|
Record UNII |
RK363YG315
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
23880
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
Dieldrin
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
RK363YG315
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
3545
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
6070
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
m11416
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID40871534
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
17821
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
9951
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY | |||
|
60-70-8
Created by
admin on Sat Dec 16 10:47:49 GMT 2023 , Edited by admin on Sat Dec 16 10:47:49 GMT 2023
|
PRIMARY |